Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If she is not, time for her to learn about it and spend your hard earned dollars so I can make good on my investment. LOL
http://www.mandarake.co.jp/en/shop/
Ask your daughter if she is familiar with Mandarake, does she buy stuff from them? Mandarake one of my 2 Japanese stock holdings...
Thanks. One more Q: Do you ever sleep or take rest away from PC? Everytime I ask something you reply within 2 minutes! LOL
Is there an IR for Scores? Have they ever put out an investor presentation? Any write up by newsletter writer or similar to take a look at?
Holly cow who did THAT?? Was just thinking to take some 4s myself. Doing dinner for kids cost me dearly :(
I always win in the end ;)
you shouldnt have sold any EUO as you told me you see? Theres actually good chances I bought yours myself :)
today I got into SCRH which seems to be popular around here...
I have a great Canuck one which IMHO is akin to having bought BRM at 28c like I did, but will keep shut until I have enough, hopefully soon ;)
BRM.V BIRMF
Upside wildcard remains on new contracts awarded, from the last PR:
BIOREM ANNOUNCES ORDERS TOTALLING $5.7 MILLION
Biorem Inc. has won several new orders totalling $5.7-million. The orders are for air emission abatement projects in North America.
"Of particular note is a large order for a municipality in the southern [United States], where our equipment will be replacing a competitor's system that failed to meet the customer's requirements. This demonstrates the value our customers see in our engineered solutions," said Derek S. Webb, president and chief executive officer of Biorem.
"With Biorem set to celebrate its 25th year anniversary in the fall and over 1,000 installations globally, Biorem continues to be the industry leader in innovation, reliability and performance. These recent orders are affirmation of the current market demand for a reliable partner in achieving regulatory
Now I have to question this: Whoever this competitor player might be I would assume they have installed other systems elsewhere.... if they are faulty and Biorem has done the job to replace their failed systems, couldnt we see a sludge of new orders just around the corner?
At Net Income of 8c FULLY diluted and about 18c UN-diluted shared count and backlog fully charged for a year at least, any string of new orders will send this flying in no time...
Thanks. And do you know why 2Q revenue jumped so much wrt to the the preceeding 3 quarters where the were already stating 14 licensees? Is it due to seasonality ( I dont think so as men are pigs all year round <g> ) or maybe because some clubs moved from fixed payments to % of revenue during that quarter?
Where does the 35 licensees number come from?
LOL. will have to remove the header of this board.... if wife catches me on with those pics It will be difficult to explain its just work related. LMAO !
Nah. I just discovered this beauty. Now keep quiet and let me accumulate some... ;)
lots of low hanging fruit contracts awaiting GFI under SICPA marketing.... plus if you want to know what the Swiss think of EUO at these prices, check out how much UBS has bought last couple months.
Biorem wins $5.7-million in new orders
Ticker Symbol: C:BRM
Biorem wins $5.7-million in new orders
Biorem Inc (C:BRM)
Shares Issued 13,553,214
Last Close 8/28/2015 $0.45
Monday August 31 2015 - News Release
Mr. Derek Webb reports
BIOREM ANNOUNCES ORDERS TOTALLING $5.7 MILLION
Biorem Inc. has won several new orders totalling $5.7-million. The orders are for air emission abatement projects in North America.
"Of particular note is a large order for a municipality in the southern [United States], where our equipment will be replacing a competitor's system that failed to meet the customer's requirements. This demonstrates the value our customers see in our engineered solutions," said Derek S. Webb, president and chief executive officer of Biorem.
"With Biorem set to celebrate its 25th year anniversary in the fall and over 1,000 installations globally, Biorem continues to be the industry leader in innovation, reliability and performance. These recent orders are affirmation of the current market demand for a reliable partner in achieving regulatory compliance for odours and air emissions at municipal and industrial facilities," concluded Mr. Webb.
© 2015 Canjex Publishing Ltd.
This email was sent to you by Stockwatch (www.stockwatch.com) as part of your package of Stockwatch services, and in accordance with your email preferences on file. You may unsubscribe at any time, or change your email preferences within Your Account settings at the Stockwatch website. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY. You may contact Stockwatch
For further info on BRM please take a look at post I made on other board and subsequent 2 posts, think its good summary of where we stand at. BRM is my largest position now along with EUO.V. I bought average low 30s and dont plan to do anything with them before at least 1-1,20:
http://www.stockhouse.com/companies/bullboard/v.brm/biorem-inc?postid=24066650
Biorem wins $5.7-million in new orders
Ticker Symbol: C:BRM
Biorem wins $5.7-million in new orders
Biorem Inc (C:BRM)
Shares Issued 13,553,214
Last Close 8/28/2015 $0.45
Monday August 31 2015 - News Release
Mr. Derek Webb reports
BIOREM ANNOUNCES ORDERS TOTALLING $5.7 MILLION
Biorem Inc. has won several new orders totalling $5.7-million. The orders are for air emission abatement projects in North America.
"Of particular note is a large order for a municipality in the southern [United States], where our equipment will be replacing a competitor's system that failed to meet the customer's requirements. This demonstrates the value our customers see in our engineered solutions," said Derek S. Webb, president and chief executive officer of Biorem.
"With Biorem set to celebrate its 25th year anniversary in the fall and over 1,000 installations globally, Biorem continues to be the industry leader in innovation, reliability and performance. These recent orders are affirmation of the current market demand for a reliable partner in achieving regulatory compliance for odours and air emissions at municipal and industrial facilities," concluded Mr. Webb.
© 2015 Canjex Publishing Ltd.
This email was sent to you by Stockwatch (www.stockwatch.com) as part of your package of Stockwatch services, and in accordance with your email preferences on file. You may unsubscribe at any time, or change your email preferences within Your Account settings at the Stockwatch website. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY. You may contact Stockwatch
Bob, Yes I do know about the convertibles and special warrants on BRM. Note this is all in hands of big clean tech Venture Capital fund that paid 2-3 bucks for their 25% stake and obviously want an exit at a profit. When the co. ran in trouble they funded them with debt and have been extending maturities ever since.
http://www.businesswire.com/news/home/20060802005176/en/Expansion-Capital-Partners-Increases-Size-Clean-Technology#.VeMjFyXtlHx
http://www.theglobeandmail.com/report-on-business/the-key-to-survival-truly-patient-capital/article17981181/
http://www.expansioncapital.com/strategy.php
Expansion Capital's Investment Strategy
Invest in expansion stage companies: the Fund invests in growth stage companies, generally with revenues of $2-$30 million, that have a reasonable expectation of reaching $30M to $100 million in a three to five year time period.
Focus on Exits: the Fund’s focus on exits begins at the time a company is being considered for investment, and the Fund Managers must be able to see several clear and plausible exit paths – from buy-outs to sale scenarios – prior to making an investment. The Fund Managers draw upon a broad network of financial and strategic investors to help a portfolio company through the exit process.
The debt is not an overwhelming burden and large portion of it will be cleaned up by year end and some already has been. Profits are more then capable of covering all scheduled debt payments shown in last paragraph. Total debt is less then 1 yrs profits so they in good shape..
6. Long-term debt March December 2015 2014 $ $ 12.75 % debenture (maturity amount - $1,485,000) 1,485,000 1,655,000 8% convertible debenture Series 1 (maturity amount - $811,274) 803,079 768,827 8% convertible debenture Series 2 (maturity amount - $1,358,952) 1,161,267 1,109,363 3,449,346 3,533,190 Less: current portion (2,288,079) (2,423,827) Long-term debt 1,161,267 1,109,363
Biorem Inc. Notes to the consolidated interim financial statements March 31, 2015 and 2014 (unaudited) 11 6. Long-term debt (continued) On March 31, 2015, the Company signed an amendment to the 12.75% debenture agreement amending the repayment terms. Under the revised terms, $200,000 of principal was due on March 31, 2015 and $50,000 due on July 31, 2015, $200,000 on August 31, 2015, $50,000 on each of September, October and November 2015 and the balance on December 31, 2015.
http://www.stockwatch.com/News/Sedardoc.aspx?docid=3390034
I will go on a limb and say BRM gets sold within 12-18 months with the Venture Capital Fund converting the 7M warrants at 0.175 which would end up cleaning BRM´s balance sheet, giving them control of about 10M shares / over 20M total outstanding. At this point BRM could be sold for 30M or 1.50/ share making good on Expansion´s Capital investment and a 5 bagger for me. :)
OTOH I would be very wary of a company like LM capable of diluting its fully diluted share count (22 to 32) by 45%(!) back in April for a mere 500,000 bucks, Big red flag to me....
LM looks nice but will have to choke through 5M shares and 5M warrants that just became free trading. thats a lot of paper to chew on. Have a look at BRM.V 45c, made 5c last Q and 4c on 1st Q, will repeat performance rest of year for sure (see backlog and outlook comments), is very very tight as has only 13M shares out and a lot on insider hands.
Lingo Media closes $500,000 private placement
2015-04-17 18:35 ET - News Release
Mr. Michael Kraft reports
LINGO MEDIA CLOSES PRIVATE PLACEMENT FINANCING
Lingo Media Corp. has closed a non-brokered private placement financing of five million units at 10 cents per unit for gross proceeds of $500,000. Each unit comprises one common share in the capital of the company and one common share purchase warrant. Each warrant entitles the holder to purchase one common share at an exercise price of 12.5 cents per share until April 17, 2016. One director of Lingo Media purchased $40,000 of the units, and declared a conflict and recused himself from voting on the financing. There was no materially contrary view or abstention by any director approving the financing. Pursuant to Multilateral Instrument 61-101, protection of minority securityholders in special transactions, the purchase by the purchasing director was a related-party transaction, but the company was exempt from the requirements to obtain a formal valuation or minority shareholder approval in connection with the financing.
The securities issued pursuant to the financing will be subject to a four-month regulatory hold period commencing from April 17, 2015. The financing is subject to TSX Venture Exchange acceptance of requisite regulatory filings. Immediately following the closing of this financing, Lingo has 27,379,177 common shares issued and outstanding. The net proceeds of the financing will be used for corporate development and for general working capital purposes.
We seek Safe Harbor.
© 2015 Canjex Publishing Ltd. All rights reserved.
Biorem Inc. (BRM, TSX-V) Update
Is there value on the Venture right now?…absolutely, though follow the 80/20 rule – only 20% of the companies are really worth considering, the other 80% are junk…within that 20%, you can narrow things down even more to the very best opportunities…
Our last update on Biorem was August 7 when it was trading around 30 cents…this morning the company reported its Q2 financial results, showing net earnings for the quarter of $718,000 or 5 per share (undiluted)…this brings net earnings for the 1st half of the fiscal year (January 1 to June 30) to $1.25 million or 9 cents per share (vs. a net loss of $1.36 million for the 1st 6 months of 2014)…
Biorem’s revenues for Q2 were $4.7 million, a 91% increase over the $2.2 million in revenue recorded during the same period last year and consistent with the $4.7 million recorded in Q1…year-to-date revenue has totaled $9.4 million, a $5 million or 112% jump in revenue over the 1st half of 2014…the revenue increase came from each of the geographic markets in which Biorem operates…
Biorem, which has only 13 million shares outstanding, is an environmental biotechnology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds and hazardous air pollutants…
“The company is well positioned to deliver consistent results for the second half of the year,” said Derek S. Webb, President and CEO. “Overall booking activity in the near term is expected to be consistent with the previous two quarters. We expect continued growth in our overseas markets as new regulatory structures are implemented to curb the release of greenhouse gas emissions and communities demand a higher quality of life free of nuisance conditions.”
Technically, what’s interesting about BRM is the fact that it’s very close to confirming a breakout above a downtrend line that has been in place for several years as shown in this 10-year monthly chart…all aspects of this chart are encouraging…this company is making money, and that’s a rarity on the Venture…
http://bullmarketrun.com/wp-content/uploads/2015/08/BRM-Aug-27.jpg
yup.... I see them cleaning up the convertible debt in 9-12m then its a no brainer bought at this level if they can keep up earnings anywhere close wehre they are now. I bought out huge during the summer doldrums below 30c. Wake me up when it hits 1 buck :)
From MD&A its pretty obvious the next 2 quarters going to be again blowout ones with revenues north of 4M again same as in 1Q and 2Q...
The value of the Company’s order backlog at June 30, 2015 decreased slightly by $285,000 to
$14.4 million from the $14.7 million order backlog at March 31, 2015 and has increased by $4.7
million or 49% over the backlog at June 30, 2014. The increase in order backlog at June 30,
2015 compared to June 30, 2014 is largely the result of higher bookings over the past 12
months compared to the period July 1, 2013 to June 30, 2014.
Due to customer scheduling, the Company cannot provide precise guidance as to the quarters
when the Backlog will be converted into revenue however management’s current estimate is
that more than 50% of the Backlog will be converted into revenue by December 31, 2015.
Also:
Overall booking activity is expected to be consistent with the previous two quarters in the near
term. Given the tendency for delays in construction or financing for large infrastructure projects,
we do expect some variability in revenue and booking between quarters, but do not anticipate
any major corrections for the remainder of the year. Growth in some of our overseas markets
will continue to develop as new regulatory structures are implemented to curb the release of
greenhouse gas emissions and communities demand a higher quality of life free of nuisance
conditions.
Product development continues in several areas to address the needs of fast growing
developing countries and the burgeoning domestic renewable energy market
BRM.V 0.35 : Amazing numbers for 5M mkt cap company paying off debt fast
Biorem earns $718,000 in Q2
2015-08-27 08:20 ET - News Release
Mr. Derek Webb reports
BIOREM REPORTS $718,000 NET EARNINGS FOR THE SECOND QUARTER
Biorem Inc. has provided its results for the three- and six-month periods ended June 30, 2015. Biorem's complete second quarter financial statements and management's discussion and analysis (MD&A) have been filed on SEDAR.
FINANCIAL HIGHLIGHTS
(thousands of dollars)
Three months ended Six months ended
June 30, June 30,
2015 2014 2015 2014
Revenue $4,709 $2,459 $9,398 $4,433
Gross profit 1,656 56 3,188 385
Operating expenses 818 748 1,651 1,482
EBITDA* 862 (623) 1,605 (965)
Net earnings (loss) 718 (835) 1,247 (1,366)
EPS -- basic 0.05 (0.06) 0.09 (0.11)
EPS -- fully diluted 0.02 (0.06) 0.04 (0.11)
* Earnings before interest, taxes and amortization, a non-IFRS (international
financial reporting standards) financial measure
Biorem's revenues for the second quarter were $4.7-million, a 91-per-cent increase over the $2.2-million in revenue recorded in the second quarter of 2014 and consistent with the $4.7-million recorded in the first quarter of 2015. Year-to-date revenue totalled $9.4-million, a $5-million or 112-per-cent increase in revenue over the first six months of 2014. The revenue increase came from each of the geographic markets in which Biorem operates.
Gross profit for the quarter was $1.7-million or 35 per cent of revenue compared with $56,000 recorded during the second quarter of 2014 and $1.5-million or 33 per cent of revenue in the first quarter of 2015. Total operating expenses (net of other income) for the quarter were $816,000. EBITDA for the quarter was $862,000 compared with an EBITDA of negative $623,000 in the second quarter of 2014.
Net earnings for the quarter were $718,000, which represents five cents per share basic and two cents on a fully diluted basis, compared with a net loss of $835,000 or six cents per share on a basic and fully diluted basis in the second quarter of 2014.
"Biorem's improved financial performance in the first half of 2015 is due to the work of our experienced staff and seasoned managers," said Derek S. Webb, president and chief executive officer. "The company is well positioned to deliver consistent results for the second half of the year. Overall booking activity in the near term is expected to be consistent with the previous two quarters. We expect continued growth in our overseas markets as new regulatory structures are implemented to curb the release of greenhouse gas emissions and communities demand a higher quality of life free of nuisance conditions."
Unrestricted cash on hand increased during the quarter to $2-million. Operating activities provided $809,000 of cash and changes in non-cash working capital provided another $100,000. Fifty thousand dollars of cash was used to pay interest during the quarter.
In March of 2015 the company negotiated an amendment to its 12.75 per cent debenture agreement amending the repayment terms and extending the maturity date to Dec. 31, 2015. Under the amended payment terms, principal payments of $200,000 due on March 31 and July 31, 2015, have been paid.
Bookings during the quarter were $4.5-million resulting in an order backlog of $14.4-million on June 30, 2015.
© 2015 Canjex Publishing Ltd. All rights reserved.
BRM.V : Wow, Blowout earnings for 4M mkt cap stock.....
Biorem earns $718,000 in Q2
2015-08-27 08:20 ET - News Release
Mr. Derek Webb reports
BIOREM REPORTS $718,000 NET EARNINGS FOR THE SECOND QUARTER
Biorem Inc. has provided its results for the three- and six-month periods ended June 30, 2015. Biorem's complete second quarter financial statements and management's discussion and analysis (MD&A) have been filed on SEDAR.
FINANCIAL HIGHLIGHTS
(thousands of dollars)
Three months ended Six months ended
June 30, June 30,
2015 2014 2015 2014
Revenue $4,709 $2,459 $9,398 $4,433
Gross profit 1,656 56 3,188 385
Operating expenses 818 748 1,651 1,482
EBITDA* 862 (623) 1,605 (965)
Net earnings (loss) 718 (835) 1,247 (1,366)
EPS -- basic 0.05 (0.06) 0.09 (0.11)
EPS -- fully diluted 0.02 (0.06) 0.04 (0.11)
* Earnings before interest, taxes and amortization, a non-IFRS (international
financial reporting standards) financial measure
Biorem's revenues for the second quarter were $4.7-million, a 91-per-cent increase over the $2.2-million in revenue recorded in the second quarter of 2014 and consistent with the $4.7-million recorded in the first quarter of 2015. Year-to-date revenue totalled $9.4-million, a $5-million or 112-per-cent increase in revenue over the first six months of 2014. The revenue increase came from each of the geographic markets in which Biorem operates.
Gross profit for the quarter was $1.7-million or 35 per cent of revenue compared with $56,000 recorded during the second quarter of 2014 and $1.5-million or 33 per cent of revenue in the first quarter of 2015. Total operating expenses (net of other income) for the quarter were $816,000. EBITDA for the quarter was $862,000 compared with an EBITDA of negative $623,000 in the second quarter of 2014.
Net earnings for the quarter were $718,000, which represents five cents per share basic and two cents on a fully diluted basis, compared with a net loss of $835,000 or six cents per share on a basic and fully diluted basis in the second quarter of 2014.
"Biorem's improved financial performance in the first half of 2015 is due to the work of our experienced staff and seasoned managers," said Derek S. Webb, president and chief executive officer. "The company is well positioned to deliver consistent results for the second half of the year. Overall booking activity in the near term is expected to be consistent with the previous two quarters. We expect continued growth in our overseas markets as new regulatory structures are implemented to curb the release of greenhouse gas emissions and communities demand a higher quality of life free of nuisance conditions."
Unrestricted cash on hand increased during the quarter to $2-million. Operating activities provided $809,000 of cash and changes in non-cash working capital provided another $100,000. Fifty thousand dollars of cash was used to pay interest during the quarter.
In March of 2015 the company negotiated an amendment to its 12.75 per cent debenture agreement amending the repayment terms and extending the maturity date to Dec. 31, 2015. Under the amended payment terms, principal payments of $200,000 due on March 31 and July 31, 2015, have been paid.
Bookings during the quarter were $4.5-million resulting in an order backlog of $14.4-million on June 30, 2015.
© 2015 Canjex Publishing Ltd. All rights reserved.
BRM.V : Blowout earnings for 4M mkt cap stock.....
Biorem earns $718,000 in Q2
2015-08-27 08:20 ET - News Release
Mr. Derek Webb reports
BIOREM REPORTS $718,000 NET EARNINGS FOR THE SECOND QUARTER
Biorem Inc. has provided its results for the three- and six-month periods ended June 30, 2015. Biorem's complete second quarter financial statements and management's discussion and analysis (MD&A) have been filed on SEDAR.
FINANCIAL HIGHLIGHTS
(thousands of dollars)
Three months ended Six months ended
June 30, June 30,
2015 2014 2015 2014
Revenue $4,709 $2,459 $9,398 $4,433
Gross profit 1,656 56 3,188 385
Operating expenses 818 748 1,651 1,482
EBITDA* 862 (623) 1,605 (965)
Net earnings (loss) 718 (835) 1,247 (1,366)
EPS -- basic 0.05 (0.06) 0.09 (0.11)
EPS -- fully diluted 0.02 (0.06) 0.04 (0.11)
* Earnings before interest, taxes and amortization, a non-IFRS (international
financial reporting standards) financial measure
Biorem's revenues for the second quarter were $4.7-million, a 91-per-cent increase over the $2.2-million in revenue recorded in the second quarter of 2014 and consistent with the $4.7-million recorded in the first quarter of 2015. Year-to-date revenue totalled $9.4-million, a $5-million or 112-per-cent increase in revenue over the first six months of 2014. The revenue increase came from each of the geographic markets in which Biorem operates.
Gross profit for the quarter was $1.7-million or 35 per cent of revenue compared with $56,000 recorded during the second quarter of 2014 and $1.5-million or 33 per cent of revenue in the first quarter of 2015. Total operating expenses (net of other income) for the quarter were $816,000. EBITDA for the quarter was $862,000 compared with an EBITDA of negative $623,000 in the second quarter of 2014.
Net earnings for the quarter were $718,000, which represents five cents per share basic and two cents on a fully diluted basis, compared with a net loss of $835,000 or six cents per share on a basic and fully diluted basis in the second quarter of 2014.
"Biorem's improved financial performance in the first half of 2015 is due to the work of our experienced staff and seasoned managers," said Derek S. Webb, president and chief executive officer. "The company is well positioned to deliver consistent results for the second half of the year. Overall booking activity in the near term is expected to be consistent with the previous two quarters. We expect continued growth in our overseas markets as new regulatory structures are implemented to curb the release of greenhouse gas emissions and communities demand a higher quality of life free of nuisance conditions."
Unrestricted cash on hand increased during the quarter to $2-million. Operating activities provided $809,000 of cash and changes in non-cash working capital provided another $100,000. Fifty thousand dollars of cash was used to pay interest during the quarter.
In March of 2015 the company negotiated an amendment to its 12.75 per cent debenture agreement amending the repayment terms and extending the maturity date to Dec. 31, 2015. Under the amended payment terms, principal payments of $200,000 due on March 31 and July 31, 2015, have been paid.
Bookings during the quarter were $4.5-million resulting in an order backlog of $14.4-million on June 30, 2015.
© 2015 Canjex Publishing Ltd. All rights reserved.
BRM.V CAD 0.265 : Here´s another stock for the fans of absurdly valued Canadian micro cap stocks. I urge everyone to take a good look at their financials and valuation, it is just mindblowing, havent seen a cheaper stock in a long long time if ever ....
Biorem earns $528,000 in Q1 2015
2015-06-01 16:10 ET - News Release
Mr. Derek Webb reports
BIOREM REPORTS INCREASED REVENUES AND EARNINGS FOR FIRST QUARTER
Biorem Inc. has released its results for the three-month period ended March 31, 2015. Biorem's complete 2015 first quarter financial statements and management discussion and analysis have been filed on SEDAR.
FINANCIAL SUMMARY
(in thousands of dollars, except per-share data)
Three months ended March 31,
2015 2014
Revenue $ 4,689 $ 1,974
Gross profit 1,531 329
EBITDA 720 (318)
Net earnings (loss) 528 (531)
Basic earnings (loss) per share 0.04 (0.04)
Diluted earnings (loss) per share 0.02 (0.04)
Revenues for the quarter totalled $4.7-million, an 18-per-cent increase over the previous quarter, and $2.7-million, or a 138-per-cent increase from revenues of $1.9-million recorded during the first quarter of 2014. The increase in 2015 first quarter revenues was a result of the substantially higher order backlog at Dec. 31, 2014.
Gross profit increased by $156,000 from the previous quarter to $1.5-million, representing 32.7 per cent of revenue, compared with $329,000 of gross profit achieved in the first three months of 2014, representing 16.7 per cent of revenue. This increase in gross profit was the result of the increased volume of business, and the 16-per-cent increase in gross profit percentage was due to the fixed costs of engineering and operations that remained consistent with the previous corresponding quarter, representing a lower percentage of cost of goods sold.
Operating expenses in the quarter of $834,000 were $100,000 higher than in the same period in the previous year; the increase was largely the result of higher sales commissions earned on the higher revenue recorded.
The company's unrestricted cash position stood at $1.3-million on March 31, 2015, compared with $1.2-million held on Dec. 31, 2014. Working capital stood at $1.4-million compared with $584,000 at Dec. 31, 2014, and a working capital deficit of $86,000 at March 31, 2014. During the quarter, the company repaid $200,000 of long-term debt.
The company booked new orders totalling $4.5-million in the quarter, resulting in a backlog of orders at March 31, 2015, of $14.7-million, compared with $8.6-million at March 31, 2014.
"Booking activity in late 2014 and the first quarter of 2015 has been strong, helping to provide a healthy backlog for the rest of the year," said Derek S. Webb, president and chief executive officer. "This continuing positive trend is a reflection of municipalities selecting a reliable option for odour control.
"Two consecutive quarters of increased bookings, revenue, working capital and reduced expenses have improved the financial health of the company, placing it in a stronger condition. With urban encroachment on infrastructure posing challenges to the operation of waste water facilities; safe, efficient solutions with small carbon footprints are being chosen for those high-profile applications. Biorem's engineered media and innovative designs are well positioned to take advantage of these needs."
Subsequent to March 31, 2015, the holders of $659,000 of convertible debentures agreed to extend the maturity date of the debentures from May 5, 2015, to Aug. 16, 2016.
Biorem receives $2.5-million of orders
2015-06-11 14:00 ET - News Release
Mr. Derek Webb reports
BIOREM ANNOUNCES ORDERS TOTALLING $2.5 MILLION
Biorem Inc. has received several new orders totalling $2.5-million. The orders are for air emission abatement projects in North America, the Middle East and Asia.
"These recent orders are a reflection of our customers' desires for reliability and the ability to achieve stringent performance targets," said Derek S. Webb, president and chief executive officer. "Each of these orders are from repeat customers who are accustomed to having their projects successfully completed on time and on budget. These projects are in the semiconductor, petrochemical, as well as the food and beverage sectors, and represent a cross-section of the potential applications where our advanced biological solutions can be effectively applied."
This doesnt catch those stocks that have been added with a later trade right? Or else you forgot to add my EUO.V then.....
RDHL is the current #1 holding of one of the Marketocracy Masters, my good friend Marcus Eder:
http://marketocracy.com/managers.php?manager=21
http://marketocracy.com/managers.php?manager=21#top-5-holdings
Great minds think alike ! ;)
XBC.V now sittign at a double after my reco just a mont ago. OK, I give you another Canadian micro cap with explosive potential to do DD on:
NTG Clarity Networks Announces Record First Quarter 2015 Financial Results
Toronto, ON / TheNewswire / May 27, 2015 / NTG Clarity Networks Inc. (TSX.V:NCI),a world leader in the telecommunications OSS/BSS market, today reported record first quarter 2015financial results.
First Quarter highlights:
-71% increase in revenues to $5.0M
-working capital of $7.0M ($0.19 per share) and no long-term debt
-significant reduction in current bank debtfrom $3.52M at December 31, 2014 to $2.65M at March 31, 2015
-strong order backlog
During the first quarter of 2015, NTG Clarity generated record revenues of $5,002,161 as compared to $2,933,749 in the same period last year, an increase of 71%. The significant increase in revenues was primarily from contracts with existing clients that were expanded and renewed in 2014. For Q1, 2015, revenue was comprised of 53% professional services and 47% product related sales, compared to 79% and 21% respectively for the same period last year.
The Company reported a 257% increase in net income to $722,489 or $0.020 per share for the three months ended March 31, 2015, compared to net income of $202,502 or $0.006 per share for the comparable period last year.
As at March 31, 2015, NTG Clarity had positive working capital of $7,017,573 and no long-term debt.
During the first quarter of 2015, NTG Clarity collected a significant amount of receivables (over $5.5 Million or 49% of the $11,297,839 receivable value at December 31, 2014. Subsequent to quarter end, the Corporation has collected an additional $2.9 Million.
Looking towards the future, we remain committed to our growth strategy and continue to focus on growing organic operations, expanding our marketing reach geographically and enhancing our product offering. We are also looking to increase our reach through acquisitions and/or partnerships with global system integrators.
In an unrelated matter, the Company announced the following management will have share options issued; Kristine Lewis; 100,000 options; M. Adel Zaghloul; 100,000 options; and Ashraf Zaghloul; 100,000 options. Each option will be exercisable at a price of $0.30 per share and will vest upon issuance.
About NTG Clarity Networks Inc.
NTG Clarity Networks' vision is to be a global leader in providing networking solutions. As a Canadian company established in 1992, NTG Clarity has delivered networking, IT and network enabled application software solutions to network service providers and large enterprises. More than 350 network professionals provide design, engineering, implementation, software development and security expertise to the industry's leading network service providers and enterprises.
yeah, understand. no big deal anyway
Actually I picked 3 foreign stocks because RDHL is an Israeli ADR...
XBC.V ( CAD 0.055 , 39M shares out = 2.1 M Mkt cap)
Dramatic turnaround situation:
- 2nd consecutive profitable quarter ( 1c each quarter)
- 14M revenue with 40% Gross margins
- Balance sheet / Liquidity situation improving
- Recent large dump by hedge fund gives great entry point
Xebec Announces Net Income of $0.4 Million for Q4-2014 and a Net Loss of $0.8 Million for Fiscal 2014
Xebec Fiscal 2014 Fourth Quarter and Year-end Financial Results
MONTREAL, April 29, 2015 /CNW Telbec/ - Xebec Adsorption Inc. (TSXV: XBC) ("Xebec"), a provider of gas purification and filtration solutions for the natural gas, field gas, biogas, helium, and hydrogen markets, announced today its 2014 fourth quarter operating results.
Revenues of $3.9 million in the fourth quarter 2014 compared to $2.8 million for the same period in 2013, a 38.5% increase in the period.
Positive EBITDA of $0.6 million in the fourth quarter compared to $1.5 million for the same period in 2013 which included a non-recurring gain on disposal of assets for $2.7 million.
Revenues of $14.4 million in fiscal 2014 compared to $11.3 million for the same period in 2013, a 27.0% increase in the year.
Net loss of $0.8 million or ($0.02)/share in fiscal 2014 compared to a Net income of $0.4 million or $0.01/share for the same period in 2013 which included a non-recurring gain on disposal of assets for $4.5 million.
Financial Highlights:
Three months ended
December 31,
% of
Change
Twelve months ended
December 31,
% of
Change
2014
2013
2014
2013
(In millions of dollars)
(unaudited)
(unaudited)
(audited)
(audited)
Revenues
3.9
2.8
38.5%
14.4
11.3
27.0%
Gross margin
1.6
0.3
462.1%
4.9
1.6
200.2%
Gross margin as a percentage of revenues
41.5%
10.2%
34.0%
14.4%
EBITDA*
0.6
1.5
(0.4)
0.8
Net income (loss)
0.4
1.4
(0.8)
0.4
Net income (loss) per share - basic ($/share)
0.01
0.04
(0.02)
0.01
Net income (loss) per share - diluted ($/share)
0.01
0.04
(0.02)
0.01
Weighted average number of shares
39,363,867
39,363,867
39,363,867
39,363,867
As at:
December 31,
2014
December 31,
2013
Total assets
7.4
9.8
Total Long term Liabilities
0.3
1.0
Equity
0.9
2.0
As at:
April 29,
2015
April 25,
2014
Back log
6.1
9.4
* EBITDA is a non-IFRS financial measure and the Company defines it as earnings from operations excluding financial charges, taxes, foreign exchange loss (gain) and amortization.
Financial Results
Revenues
Xebec posted revenues of $3.9 million for the fourth quarter of 2014, a 38.5% increase compared to $2.8 million in the fourth quarter of 2013. The increase is explained by significant growth in the Natural Gas Dryer (NGX) segment.
For the twelve-month period ended December 31, 2014, total revenues amounted to $14.4 million compared to $11.3 million for the corresponding period. This increase of $3.1 million is partly due to the $0.8 million increase in sales in the Associated Gas (AGX) segment due to the completion of a project during 2014. Furthermore, the NGX product line showed a significant increase (+$2.2 million) in revenue for the twelve-month period ended December 31, 2014 compared to the corresponding period last year.
Order Backlog
As of April 29, 2015, total order backlog stood at $6.1 million, compared to $9.4 million as at April 25, 2014.
Gross profit margin
The gross profit margin for the fourth quarter of 2014 stood at 41.5%, almost four times growth compared to 10.2% for the fourth quarter of 2013. The improvement versus the same period last year is mostly explained by the improvement in gross margins in revenues associated with the gas purification product line and the reversal of a provision of $0.3 million created in 2013.
For the twelve-month period ended December 31, 2014 the operating profit margin stood at 34.0%, slightly more than two times higher compared to the fourth quarter of 2013. Natural gas dryer margins were improved due to a higher volume of sales which reduced the burden per unit. Improved margins also reflect the effect of the cost reduction plan introduced during 2013 for this segment. Margins for the gas purification segment were affected positively with the reversal of the $0.3 million provision mentioned above, combined with profitability of new on-going orders. The revenue increase also contributed to improved gross margin since fixed costs are absorbed by a higher volume of sales.
EBITDA and Net Income
The EBITDA for the fourth quarter of 2014 amounted to $0.6 million compared to $1.5 million in the fourth quarter of 2013. By excluding the $2.7 million non-recurring gain on disposal of assets from the EBITDA for Q4-2013, the improvement for the comparative period is $1.8 million.
For the twelve-month period ended December 31, 2014, EBITDA amounted to $(0.4) million compared to $0.8 million for the same period in 2013. The lower EBITDA number in 2014 is explained by the fact that in 2013 a $4.5 million non-recurring gain on disposal of assets was recorded. After excluding this non-recurring gain, the EBITDA has increased by $3.3 million for the comparative period.
Net income for the fourth quarter of 2014 totaled $0.4 million, or $0.01 per share, compared to a net income of $1.4 million, or $0.04 per share for the same period in 2013. Despite the fact that the margins improved by $1.3 million on increased revenue for the fourth quarter of 2014, net income is lower due to the fact that the fourth quarter of 2013 included a $2.7 million non-recurring gain on disposal of assets.
Net loss for the twelve-month period ended December 31, 2014 amounted to $0.8 million, or ($0.02) per share, compared to a net income of $0.4 million or $0.01 per share, for the same period in 2013. The increase in net loss compared to 2013 is explained by the fact that, for the corresponding period in 2013, a $4.5 million non-recurring gain on disposal of assets was included.
Selling and administrative expenses for the fourth quarter of 2014 decreased by $0.7 million or 37.1% to $1.1 million. The decrease is mainly explained by reversal of $0.2 million of bad debt provision in China and capitalization of development costs related to the new filter line of $0.3 million.
For the twelve-month period ended December 31, 2014 the selling and administrative expenses decreased by $0.3 million or 5.5% to $5.6 million. The decrease is mainly explained by reversal of $0.2 million of bad debt provision mentioned above, and the capitalization of development costs for the new filter line for $0.3 million. This was partly offset by the new USA subsidiary expenses.
As of December 31, 2014, the Company had $1.0 million of cash on hand, $0.1 million of bank loan and $0.8 million of debt outstanding, which is due within one year.
Xebec 2014 year-end Financial Statements and Management's Discussion and Analysis include further information on the Company.
2014 Fourth Quarter Financial Statements and Management's Discussion and Analysis
The complete audited financial statements, notes to financial statements and the Management's Discussion and Analysis for the fiscal year ended December 31, 2014, are available on the Company's Website at www.xebecinc.com and on the SEDAR Website at www.sedar.com.
About Xebec Adsorption Inc.
Xebec Adsorption Inc. is a global provider of clean energy solutions to corporations and governments looking to reduce their carbon footprints. With more than 1,500 customers worldwide, Xebec designs, engineers and manufactures innovative products that transform raw gases into marketable sources of clean energy mainly used as transportation fuel. Xebec's strategy is focused on establishing leadership positions in markets where demand for biogas upgrading, natural gas dehydration, liquefaction and hydrogen purification is growing. Headquartered in Montreal (QC), Xebec is a global company with two manufacturing facilities in Montreal and Shanghai, as well as a sales and distribution network in North America and Asia. Xebec trades on the TSXV under the symbol XBC. Since February 25th 2014, Xebec has opened a sales office in Houston, Texas (USA), in order to cover sales opportunities in the United States. For additional information on the company and its products and services, please visit the Xebec web site at www.xebecinc.com.
Caution Concerning Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking" statements within the meaning of applicable securities laws. This forward looking information includes, but is not limited to, the expectations and/or claims of management of Xebec with respect to information regarding the business, operations and financial condition of Xebec. Forward-looking information contained in this press release involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Xebec or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. This list is not exhaustive of the factors that may affect forward-looking information contained in this press release. When used in this press release, such statements use such words as "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "will" and other similar terminology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this presentation. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements.
SOURCE Xebec Adsorption Inc.
Kurt Sorschak, President and CEO, 450-979-8701, ksorschak@xebecinc.com; Alnoor Mandjee, Chief Financial Officer, 450-979-8700, amandjee@xebecinc.comCopyright CNW Group 2015
Source: Canada Newswire (Apr 29, 2015 18:34:00 EDT)
News by QuoteMedia
www.quotemedia.com
Xebec Announces Net Income of $0.4 Million for Q4-2014 and a Net Loss of $0.8 Million for Fiscal 2014
Xebec Fiscal 2014 Fourth Quarter and Year-end Financial Results
MONTREAL, April 29, 2015 /CNW Telbec/ - Xebec Adsorption Inc. (TSXV: XBC) ("Xebec"), a provider of gas purification and filtration solutions for the natural gas, field gas, biogas, helium, and hydrogen markets, announced today its 2014 fourth quarter operating results.
Revenues of $3.9 million in the fourth quarter 2014 compared to $2.8 million for the same period in 2013, a 38.5% increase in the period.
Positive EBITDA of $0.6 million in the fourth quarter compared to $1.5 million for the same period in 2013 which included a non-recurring gain on disposal of assets for $2.7 million.
Revenues of $14.4 million in fiscal 2014 compared to $11.3 million for the same period in 2013, a 27.0% increase in the year.
Net loss of $0.8 million or ($0.02)/share in fiscal 2014 compared to a Net income of $0.4 million or $0.01/share for the same period in 2013 which included a non-recurring gain on disposal of assets for $4.5 million.
Financial Highlights:
Three months ended
December 31,
% of
Change
Twelve months ended
December 31,
% of
Change
2014
2013
2014
2013
(In millions of dollars)
(unaudited)
(unaudited)
(audited)
(audited)
Revenues
3.9
2.8
38.5%
14.4
11.3
27.0%
Gross margin
1.6
0.3
462.1%
4.9
1.6
200.2%
Gross margin as a percentage of revenues
41.5%
10.2%
34.0%
14.4%
EBITDA*
0.6
1.5
(0.4)
0.8
Net income (loss)
0.4
1.4
(0.8)
0.4
Net income (loss) per share - basic ($/share)
0.01
0.04
(0.02)
0.01
Net income (loss) per share - diluted ($/share)
0.01
0.04
(0.02)
0.01
Weighted average number of shares
39,363,867
39,363,867
39,363,867
39,363,867
As at:
December 31,
2014
December 31,
2013
Total assets
7.4
9.8
Total Long term Liabilities
0.3
1.0
Equity
0.9
2.0
As at:
April 29,
2015
April 25,
2014
Back log
6.1
9.4
* EBITDA is a non-IFRS financial measure and the Company defines it as earnings from operations excluding financial charges, taxes, foreign exchange loss (gain) and amortization.
Financial Results
Revenues
Xebec posted revenues of $3.9 million for the fourth quarter of 2014, a 38.5% increase compared to $2.8 million in the fourth quarter of 2013. The increase is explained by significant growth in the Natural Gas Dryer (NGX) segment.
For the twelve-month period ended December 31, 2014, total revenues amounted to $14.4 million compared to $11.3 million for the corresponding period. This increase of $3.1 million is partly due to the $0.8 million increase in sales in the Associated Gas (AGX) segment due to the completion of a project during 2014. Furthermore, the NGX product line showed a significant increase (+$2.2 million) in revenue for the twelve-month period ended December 31, 2014 compared to the corresponding period last year.
Order Backlog
As of April 29, 2015, total order backlog stood at $6.1 million, compared to $9.4 million as at April 25, 2014.
Gross profit margin
The gross profit margin for the fourth quarter of 2014 stood at 41.5%, almost four times growth compared to 10.2% for the fourth quarter of 2013. The improvement versus the same period last year is mostly explained by the improvement in gross margins in revenues associated with the gas purification product line and the reversal of a provision of $0.3 million created in 2013.
For the twelve-month period ended December 31, 2014 the operating profit margin stood at 34.0%, slightly more than two times higher compared to the fourth quarter of 2013. Natural gas dryer margins were improved due to a higher volume of sales which reduced the burden per unit. Improved margins also reflect the effect of the cost reduction plan introduced during 2013 for this segment. Margins for the gas purification segment were affected positively with the reversal of the $0.3 million provision mentioned above, combined with profitability of new on-going orders. The revenue increase also contributed to improved gross margin since fixed costs are absorbed by a higher volume of sales.
EBITDA and Net Income
The EBITDA for the fourth quarter of 2014 amounted to $0.6 million compared to $1.5 million in the fourth quarter of 2013. By excluding the $2.7 million non-recurring gain on disposal of assets from the EBITDA for Q4-2013, the improvement for the comparative period is $1.8 million.
For the twelve-month period ended December 31, 2014, EBITDA amounted to $(0.4) million compared to $0.8 million for the same period in 2013. The lower EBITDA number in 2014 is explained by the fact that in 2013 a $4.5 million non-recurring gain on disposal of assets was recorded. After excluding this non-recurring gain, the EBITDA has increased by $3.3 million for the comparative period.
Net income for the fourth quarter of 2014 totaled $0.4 million, or $0.01 per share, compared to a net income of $1.4 million, or $0.04 per share for the same period in 2013. Despite the fact that the margins improved by $1.3 million on increased revenue for the fourth quarter of 2014, net income is lower due to the fact that the fourth quarter of 2013 included a $2.7 million non-recurring gain on disposal of assets.
Net loss for the twelve-month period ended December 31, 2014 amounted to $0.8 million, or ($0.02) per share, compared to a net income of $0.4 million or $0.01 per share, for the same period in 2013. The increase in net loss compared to 2013 is explained by the fact that, for the corresponding period in 2013, a $4.5 million non-recurring gain on disposal of assets was included.
Selling and administrative expenses for the fourth quarter of 2014 decreased by $0.7 million or 37.1% to $1.1 million. The decrease is mainly explained by reversal of $0.2 million of bad debt provision in China and capitalization of development costs related to the new filter line of $0.3 million.
For the twelve-month period ended December 31, 2014 the selling and administrative expenses decreased by $0.3 million or 5.5% to $5.6 million. The decrease is mainly explained by reversal of $0.2 million of bad debt provision mentioned above, and the capitalization of development costs for the new filter line for $0.3 million. This was partly offset by the new USA subsidiary expenses.
As of December 31, 2014, the Company had $1.0 million of cash on hand, $0.1 million of bank loan and $0.8 million of debt outstanding, which is due within one year.
Xebec 2014 year-end Financial Statements and Management's Discussion and Analysis include further information on the Company.
2014 Fourth Quarter Financial Statements and Management's Discussion and Analysis
The complete audited financial statements, notes to financial statements and the Management's Discussion and Analysis for the fiscal year ended December 31, 2014, are available on the Company's Website at www.xebecinc.com and on the SEDAR Website at www.sedar.com.
About Xebec Adsorption Inc.
Xebec Adsorption Inc. is a global provider of clean energy solutions to corporations and governments looking to reduce their carbon footprints. With more than 1,500 customers worldwide, Xebec designs, engineers and manufactures innovative products that transform raw gases into marketable sources of clean energy mainly used as transportation fuel. Xebec's strategy is focused on establishing leadership positions in markets where demand for biogas upgrading, natural gas dehydration, liquefaction and hydrogen purification is growing. Headquartered in Montreal (QC), Xebec is a global company with two manufacturing facilities in Montreal and Shanghai, as well as a sales and distribution network in North America and Asia. Xebec trades on the TSXV under the symbol XBC. Since February 25th 2014, Xebec has opened a sales office in Houston, Texas (USA), in order to cover sales opportunities in the United States. For additional information on the company and its products and services, please visit the Xebec web site at www.xebecinc.com.
Caution Concerning Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking" statements within the meaning of applicable securities laws. This forward looking information includes, but is not limited to, the expectations and/or claims of management of Xebec with respect to information regarding the business, operations and financial condition of Xebec. Forward-looking information contained in this press release involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Xebec or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. This list is not exhaustive of the factors that may affect forward-looking information contained in this press release. When used in this press release, such statements use such words as "anticipate", "believe", "plan", "estimate", "expect", "intend", "may", "will" and other similar terminology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this presentation. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements.
SOURCE Xebec Adsorption Inc.
Kurt Sorschak, President and CEO, 450-979-8701, ksorschak@xebecinc.com; Alnoor Mandjee, Chief Financial Officer, 450-979-8700, amandjee@xebecinc.comCopyright CNW Group 2015
Source: Canada Newswire (Apr 29, 2015 18:34:00 EDT)
News by QuoteMedia
www.quotemedia.com
thank you. Anyone have access to Cantor Fitzgerald reports , please PM me ... TIA
is contest open now for next quarter?
yup. huge volume in Israel and US closed above actual conversion price to USD which I have never seen before.... so something might be cooking
yup. I hold substantial investment here......
USD tanking.... thats why
when is REX next earnings release? TIA
be interesting if anyone can run a quick comp btw EDV.TO and BAA to see how cheap we are compared to our closest peer. Mkt cap/debt/EV/Production/Margins and the like....
This turd keeps on dropping every f day!!!! LMAO!